Combining Aspirin With Oral Anticoagulant Therapy. Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?

doi:10.1161/STROKEAHA.107.485250

Published Online
on March 29, 2007

Stroke. 2007
Published online before print March 29, 2007, doi: 10.1161/STROKEAHA.107.485250

A more recent version of this article appeared on May 1, 2007

This Article

	Full Text (PDF)
	All Versions of this Article: 38/5/1652 most recent STROKEAHA.107.485250v1
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Request Permissions

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Gorelick, P. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Gorelick, P. B.


Related Collections

	Anticoagulants

Submitted on February 13, 2007
Accepted on February 21, 2007

Combining Aspirin With Oral Anticoagulant Therapy. Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?

Philip B. Gorelick MD, MPH^*

From the Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, Ill.

^* To whom correspondence should be addressed. E-mail: pgorelic{at}uic.edu.

Key words: aspirin • bleeding complications • warfarin • ximelagatran

This article has been cited by other articles:

P. B. Gorelick
Cerebral Microbleeds: Evidence of Heightened Risk Associated With Aspirin Use
Arch Neurol, June 1, 2009; 66(6): 691 - 693.
[Full Text] [PDF]

A. J. Furlan
Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention?: Yes
Stroke, May 1, 2009; 40(5): 1942 - 1943.
[Full Text] [PDF]

K. Toyoda, M. Yasaka, K. Iwade, K. Nagata, Y. Koretsune, T. Sakamoto, S. Uchiyama, J. Gotoh, T. Nagao, M. Yamamoto, et al.
Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study
Stroke, June 1, 2008; 39(6): 1740 - 1745.
[Abstract] [Full Text] [PDF]

A. Ono, I. Kawamura, and T. Fujita
Letter Regarding Article by Hylek et al, "Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation"
Circulation, November 13, 2007; 116(20): e538 - e538.
[Full Text] [PDF]

T. Watson and G. Y.H. Lip
Combining Antiplatelet Drugs and Oral Anticoagulant Therapy in Atrial Fibrillation: Acute Coronary Syndromes and/or Percutaneous Coronary Intervention/Stenting Revisited
Stroke, October 1, 2007; 38(10): e107 - e108.
[Full Text] [PDF]

				A. J. Furlan Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention?: Yes Stroke, May 1, 2009; 40(5): 1942 - 1943. [Full Text] [PDF]

				K. Toyoda, M. Yasaka, K. Iwade, K. Nagata, Y. Koretsune, T. Sakamoto, S. Uchiyama, J. Gotoh, T. Nagao, M. Yamamoto, et al. Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study Stroke, June 1, 2008; 39(6): 1740 - 1745. [Abstract] [Full Text] [PDF]

				A. Ono, I. Kawamura, and T. Fujita Letter Regarding Article by Hylek et al, "Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation" Circulation, November 13, 2007; 116(20): e538 - e538. [Full Text] [PDF]

				T. Watson and G. Y.H. Lip Combining Antiplatelet Drugs and Oral Anticoagulant Therapy in Atrial Fibrillation: Acute Coronary Syndromes and/or Percutaneous Coronary Intervention/Stenting Revisited Stroke, October 1, 2007; 38(10): e107 - e108. [Full Text] [PDF]